Compile Data Set for Download or QSAR
Report error Found 18 Enz. Inhib. hit(s) with all data for entry = 12370
TargetSodium-dependent dopamine transporter(Rat)
Transcend Therapeutics

US Patent
LigandPNGBDBM50114073(CHEMBL3604010 | US20240327372, Compound Racemic me...)
Affinity DataIC50: 3.10E+3nMAssay Description:Competition binding assays were carried out in 96-well polypropylene plates in a final volume of 250 μL per well. To each well was added 150 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/3/2025
Entry Details
Go to US Patent

TargetSodium-dependent dopamine transporter(Rat)
Transcend Therapeutics

US Patent
LigandPNGBDBM698944(US20240327372, Compound (R)-methylone)
Affinity DataIC50: 4.67E+3nMAssay Description:Competition binding assays were carried out in 96-well polypropylene plates in a final volume of 250 μL per well. To each well was added 150 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/3/2025
Entry Details
Go to US Patent

TargetSodium-dependent serotonin transporter(Rat)
Transcend Therapeutics

US Patent
LigandPNGBDBM698945(US20240327372, Compound (S)-methylone)
Affinity DataIC50: 6.52E+3nMAssay Description:Competition binding assays were carried out in 96-well polypropylene plates in a final volume of 250 μL per well. To each well was added 150 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/3/2025
Entry Details
Go to US Patent

TargetSodium-dependent dopamine transporter(Rat)
Transcend Therapeutics

US Patent
LigandPNGBDBM50114073(CHEMBL3604010 | US20240327372, Compound Racemic me...)
Affinity DataIC50: 7.11E+3nMAssay Description:Competition binding assays were carried out in 96-well polypropylene plates in a final volume of 250 μL per well. To each well was added 150 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/3/2025
Entry Details
Go to US Patent

TargetSodium-dependent dopamine transporter(Rat)
Transcend Therapeutics

US Patent
LigandPNGBDBM698945(US20240327372, Compound (S)-methylone)
Affinity DataIC50: 7.12E+3nMAssay Description:Competition binding assays were carried out in 96-well polypropylene plates in a final volume of 250 μL per well. To each well was added 150 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/3/2025
Entry Details
Go to US Patent

TargetSodium-dependent dopamine transporter(Rat)
Transcend Therapeutics

US Patent
LigandPNGBDBM698945(US20240327372, Compound (S)-methylone)
Affinity DataIC50: 8.34E+3nMAssay Description:Competition binding assays were carried out in 96-well polypropylene plates in a final volume of 250 μL per well. To each well was added 150 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/3/2025
Entry Details
Go to US Patent

TargetSodium-dependent serotonin transporter(Rat)
Transcend Therapeutics

US Patent
LigandPNGBDBM50114073(CHEMBL3604010 | US20240327372, Compound Racemic me...)
Affinity DataIC50: 1.23E+4nMAssay Description:Competition binding assays were carried out in 96-well polypropylene plates in a final volume of 250 μL per well. To each well was added 150 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/3/2025
Entry Details
Go to US Patent

TargetSodium-dependent dopamine transporter(Rat)
Transcend Therapeutics

US Patent
LigandPNGBDBM698944(US20240327372, Compound (R)-methylone)
Affinity DataIC50: 2.47E+4nMAssay Description:Competition binding assays were carried out in 96-well polypropylene plates in a final volume of 250 μL per well. To each well was added 150 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/3/2025
Entry Details
Go to US Patent

TargetSodium-dependent serotonin transporter(Rat)
Transcend Therapeutics

US Patent
LigandPNGBDBM698944(US20240327372, Compound (R)-methylone)
Affinity DataIC50: 3.47E+4nMAssay Description:Competition binding assays were carried out in 96-well polypropylene plates in a final volume of 250 μL per well. To each well was added 150 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/3/2025
Entry Details
Go to US Patent

TargetSodium-dependent dopamine transporter(Rat)
Transcend Therapeutics

US Patent
LigandPNGBDBM50114073(CHEMBL3604010 | US20240327372, Compound Racemic me...)
Affinity DataKi:  1.46E+3nMAssay Description:Competition binding assays were carried out in 96-well polypropylene plates in a final volume of 250 μL per well. To each well was added 150 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/3/2025
Entry Details
Go to US Patent

TargetSodium-dependent dopamine transporter(Rat)
Transcend Therapeutics

US Patent
LigandPNGBDBM698944(US20240327372, Compound (R)-methylone)
Affinity DataKi:  2.19E+3nMAssay Description:Competition binding assays were carried out in 96-well polypropylene plates in a final volume of 250 μL per well. To each well was added 150 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/3/2025
Entry Details
Go to US Patent

TargetSodium-dependent dopamine transporter(Rat)
Transcend Therapeutics

US Patent
LigandPNGBDBM698945(US20240327372, Compound (S)-methylone)
Affinity DataKi:  3.37E+3nMAssay Description:Competition binding assays were carried out in 96-well polypropylene plates in a final volume of 250 μL per well. To each well was added 150 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/3/2025
Entry Details
Go to US Patent

TargetSodium-dependent dopamine transporter(Rat)
Transcend Therapeutics

US Patent
LigandPNGBDBM50114073(CHEMBL3604010 | US20240327372, Compound Racemic me...)
Affinity DataKi:  3.53E+3nMAssay Description:Competition binding assays were carried out in 96-well polypropylene plates in a final volume of 250 μL per well. To each well was added 150 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/3/2025
Entry Details
Go to US Patent

TargetSodium-dependent serotonin transporter(Rat)
Transcend Therapeutics

US Patent
LigandPNGBDBM698945(US20240327372, Compound (S)-methylone)
Affinity DataKi:  3.95E+3nMAssay Description:Competition binding assays were carried out in 96-well polypropylene plates in a final volume of 250 μL per well. To each well was added 150 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/3/2025
Entry Details
Go to US Patent

TargetSodium-dependent dopamine transporter(Rat)
Transcend Therapeutics

US Patent
LigandPNGBDBM698945(US20240327372, Compound (S)-methylone)
Affinity DataKi:  4.14E+3nMAssay Description:Competition binding assays were carried out in 96-well polypropylene plates in a final volume of 250 μL per well. To each well was added 150 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/3/2025
Entry Details
Go to US Patent

TargetSodium-dependent serotonin transporter(Rat)
Transcend Therapeutics

US Patent
LigandPNGBDBM50114073(CHEMBL3604010 | US20240327372, Compound Racemic me...)
Affinity DataKi:  7.44E+3nMAssay Description:Competition binding assays were carried out in 96-well polypropylene plates in a final volume of 250 μL per well. To each well was added 150 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/3/2025
Entry Details
Go to US Patent

TargetSodium-dependent dopamine transporter(Rat)
Transcend Therapeutics

US Patent
LigandPNGBDBM698944(US20240327372, Compound (R)-methylone)
Affinity DataKi:  1.23E+4nMAssay Description:Competition binding assays were carried out in 96-well polypropylene plates in a final volume of 250 μL per well. To each well was added 150 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/3/2025
Entry Details
Go to US Patent

TargetSodium-dependent serotonin transporter(Rat)
Transcend Therapeutics

US Patent
LigandPNGBDBM698944(US20240327372, Compound (R)-methylone)
Affinity DataKi:  2.11E+4nMAssay Description:Competition binding assays were carried out in 96-well polypropylene plates in a final volume of 250 μL per well. To each well was added 150 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/3/2025
Entry Details
Go to US Patent